Minimal clinically important differences in the Edmonton symptom assessment system in patients with advanced cancer.

PubWeight™: 1.76‹?› | Rank: Top 3%

🔗 View Article (PMID 23177724)

Published in J Pain Symptom Manage on November 22, 2012

Authors

Gillian Bedard1, Liang Zeng, Liying Zhang, Natalie Lauzon, Lori Holden, May Tsao, Cyril Danjoux, Elizabeth Barnes, Arjun Sahgal, Michael Poon, Edward Chow

Author Affiliations

1: Rapid Response Radiotherapy Program, Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Associated clinical trials:

"LIFEView" Audiovisual Technology: Virtual Travel to Support Wellbeing and Quality of Life at the End of Life | NCT04030910

Articles citing this

Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study. Cancer (2015) 1.80

Are emergency admissions in palliative cancer care always necessary? Results from a descriptive study. BMJ Open (2013) 0.95

Minimal clinically important differences in the edmonton symptom assessment system: the anchor is key. J Pain Symptom Manage (2013) 0.92

Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System. J Pain Symptom Manage (2015) 0.91

The Edmonton Symptom Assessment System 25 Years Later: Past, Present and Future Developments. J Pain Symptom Manage (2016) 0.78

Minimally invasive palliative procedures in oncology: a review of a multidisciplinary collaboration. Support Care Cancer (2014) 0.76

The potential role for acupuncture in treating symptoms in patients with lung cancer: an observational longitudinal study. Curr Oncol (2013) 0.76

The McGill University Health Centre Cancer Pain Clinic: A Retrospective Analysis of an Interdisciplinary Approach to Cancer Pain Management. Pain Res Manag (2016) 0.76

A cluster randomized trial of a primary palliative care intervention (CONNECT)for patients with advanced cancer: Protocol and key design considerations. Contemp Clin Trials (2017) 0.75

Minimal important differences for fatigue patient reported outcome measures-a systematic review. BMC Med Res Methodol (2016) 0.75

Predictors of responses to corticosteroids for anorexia in advanced cancer patients: a multicenter prospective observational study. Support Care Cancer (2016) 0.75

Articles by these authors

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol (2009) 10.43

ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol (2006) 7.77

Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell (2008) 7.47

Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am J Pathol (2004) 6.95

Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell (2012) 5.62

Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys (2011) 3.63

Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol (2007) 3.24

Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study. Lancet Oncol (2013) 2.90

Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells (2009) 2.71

The genome of the pear (Pyrus bretschneideri Rehd.). Genome Res (2012) 2.55

Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol (2008) 2.50

Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors. Int J Radiat Oncol Biol Phys (2012) 2.45

Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci U S A (2013) 2.33

Multigeneration analysis reveals the inheritance, specificity, and patterns of CRISPR/Cas-induced gene modifications in Arabidopsis. Proc Natl Acad Sci U S A (2014) 2.26

The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer (2006) 2.22

Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity (2006) 2.21

Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15. Eur J Cancer (2010) 2.20

Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy. Eur Urol (2006) 2.13

Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol (2010) 2.12

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol (2002) 2.11

Palliative care and oncology: integration leads to better care. Oncology (Williston Park) (2011) 2.02

CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα. Cell Stem Cell (2012) 1.97

Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know. Cell Res (2006) 1.94

HIV-testing behavior among young migrant men who have sex with men (MSM) in Beijing, China. AIDS Care (2011) 1.93

Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med (2009) 1.89

Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev (2012) 1.79

Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers. Int J Radiat Oncol Biol Phys (2009) 1.75

Apparatus dependence of normal brain tissue dose in stereotactic radiosurgery for multiple brain metastases. J Neurosurg (2011) 1.71

International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice? Int J Radiat Oncol Biol Phys (2009) 1.70

Pseudoprogression following chemoradiotherapy for glioblastoma multiforme. Can J Neurol Sci (2010) 1.69

Brain edema after intracerebral hemorrhage in rats: the role of inflammation. Neurol India (2006) 1.69

Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol (2005) 1.67

Reperfusion is a stronger predictor of good clinical outcome than recanalization in ischemic stroke. Radiology (2013) 1.67

ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 1.63

A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) study. Eur Urol (2012) 1.62

Radiation-induced vertebral compression fracture following spine stereotactic radiosurgery: clinicopathological correlation. J Neurosurg Spine (2013) 1.61

How radiation oncologists evaluate and incorporate life expectancy estimates into the treatment of palliative cancer patients: a survey-based study. Int J Radiat Oncol Biol Phys (2013) 1.60

Psychometric evaluation of the Trauma Symptoms Checklist for Children (TSCC) among children affected by HIV/AIDS in China. AIDS Care (2009) 1.59

Impact of skeletal complications on patients' quality of life, mobility, and functional independence. Support Care Cancer (2008) 1.57

Accuracy of survival prediction by palliative radiation oncologists. Int J Radiat Oncol Biol Phys (2005) 1.56

Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys (2011) 1.56

Assessment of myocardial perfusion and viability from routine contrast-enhanced 16-detector-row computed tomography of the heart: preliminary results. Eur Radiol (2005) 1.55

Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev (2005) 1.54

HIV/AIDS-related sexual risk behaviors among rural residents in China: potential role of rural-to-urban migration. AIDS Educ Prev (2007) 1.53

(IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys (2002) 1.52

Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology (2007) 1.52

Glioblastoma: patterns of recurrence and efficacy of salvage treatments. Can J Neurol Sci (2011) 1.48

Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not? Int J Radiat Oncol Biol Phys (2002) 1.45

ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 1.45

Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in regard to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309). Int J Radiat Oncol Biol Phys (2008) 1.44

Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion. Radiology (2009) 1.43

Ontario radiation oncology residents' needs in the first postgraduate year-residents' perspective survey. Int J Radiat Oncol Biol Phys (2007) 1.43

Improved wait time intervals for prostate cancer patients in a multidisciplinary rapid diagnostic unit compared to a community-based referral pattern. Can Urol Assoc J (2013) 1.42

hTERT/re-caspase-3 system induce apoptosis in hTERT-positive cancer cells. Cancer Biol Ther (2006) 1.40

Chronic lymphocytic leukemia resembling metastatic bone disease-- an unusual manifestation. J Pain Symptom Manage (2003) 1.39

Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res (2007) 1.35

Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells. Circ Res (2012) 1.34

Use of in vitro HTS-derived concentration-response data as biological descriptors improves the accuracy of QSAR models of in vivo toxicity. Environ Health Perspect (2010) 1.31

Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. Circulation (2013) 1.29

A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer (2011) 1.29

Parental HIV/AIDS and psychosocial adjustment among rural Chinese children. J Pediatr Psychol (2009) 1.29

Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes. Radiother Oncol (2013) 1.28

Critical role of nucleostemin in pre-rRNA processing. J Biol Chem (2008) 1.28

DTF1 is a core component of RNA-directed DNA methylation and may assist in the recruitment of Pol IV. Proc Natl Acad Sci U S A (2013) 1.27

Quality of life in surgical treatment of metastatic spine disease. Spine (Phila Pa 1976) (2003) 1.25

Lifetime incidences of traumatic events and mental health among children affected by HIV/AIDS in rural China. J Clin Child Adolesc Psychol (2009) 1.25

Certainty of stroke diagnosis: incremental benefit with CT perfusion over noncontrast CT and CT angiography. Radiology (2010) 1.25

The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells. Biochem Biophys Res Commun (2007) 1.21

Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-gamma and nitric oxide. J Immunol (2008) 1.21

Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. Hum Pathol (2012) 1.20

A predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol Phys (2002) 1.20

The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells. Mol Endocrinol (2005) 1.19

Gamma knife radiosurgery for brainstem metastases: the UCSF experience. J Neurooncol (2007) 1.18

Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials. Support Care Cancer (2014) 1.18

A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manage (2009) 1.18

High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma. Clin Cancer Res (2006) 1.18

Pinpointing genes underlying the quantitative trait loci for root-knot nematode resistance in palaeopolyploid soybean by whole genome resequencing. Proc Natl Acad Sci U S A (2013) 1.16

Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells. Mol Immunol (2006) 1.16

Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol (2007) 1.15

Concussion in professional football: brain responses by finite element analysis: part 9. Neurosurgery (2005) 1.15

Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22. Int J Radiat Oncol Biol Phys (2012) 1.15

International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer (2011) 1.14

Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma. Int J Radiat Oncol Biol Phys (2005) 1.14

Receptive vocabulary, expressive vocabulary, and speech production of boys with fragile X syndrome in comparison to boys with down syndrome. Am J Ment Retard (2007) 1.14

Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer. Asia Pac J Clin Oncol (2013) 1.14